New User:

Forgot your password?

Stock Market & Financial Investment News

Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 >>
November 17, 2015
13:09 EDTHLFHerbalife says not aware of being named in DOJ supplement action, Bloomberg says
Subscribe for More Information
12:35 EDTHLFHerbalife puts active on headlines of DOJ briefing on supplement actions
Herbalife November 47 and 50 puts are active on total put volume of 9,800 contracts (2,400 calls) following Bloomberg headlines of DOJ briefing on supplement actions. November put option implied volatility is at 113, December is at 55; compared to its 52-week range of 34 to 126. Active put volume suggests traders taking positions for wide price movement.
12:28 EDTHLFGNC, Vitamin Shoppe, Herbalife at lows following DOJ supplement advisory
The Department of Justice said in a media advisory that it plans to announce at 3:30 pm today its actions related to dietary supplements sales and unlawful ads. Following the press advisory, shares of GNC Holdings (GNC), Vitamin Shoppe (VSI) and Herbalife (HLF) are at session lows, though none of the companies were named in the advisory.
November 16, 2015
17:10 EDTHLFSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
10:30 EDTSONSSonus management to meet with Drexel Hamilton
Subscribe for More Information
10:00 EDTORCLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alliant Energy (LNT) upgraded to Outperform from Market Perform at Wells Fargo... AmerisourceBergen (ABC) upgraded to Equal Weight from Underweight at Morgan Stanley... Amphenol (APH) upgraded to Buy from Neutral at Goldman... CA Technologies (CA) upgraded to Neutral from Sell at Citi... Cempra (CEMP) upgraded to Overweight from Equal Weight at Morgan Stanley... Edgewell Personal Care (EPC) upgraded to Neutral from Sell at Goldman... Eli Lilly (LLY) upgraded on improved growth outlook at BMO Capital... MiMedx (MDXG) upgraded to Strong Buy from Buy at Needham... NVIDIA (NVDA) upgraded to Buy from Hold at Canaccord... New York REIT (NYRT) upgraded to Buy from Hold at Evercore ISI... Oracle (ORCL) upgraded to Conviction Buy from Buy at Goldman... Perrigo (PRGO) upgraded to Buy from Neutral at UBS... Semtech (SMTC) upgraded to Buy from Neutral at B. Riley... Tullow Oil (TUWOY) upgraded to Buy from Neutral at UBS... Wabtec (WAB) upgraded to Outperform on valuatoin at Raymond James.
09:53 EDTORCLOracle rallies, levels to watch
Subscribe for More Information
09:37 EDTORCLActive equity options trading on open
Active equity options trading on open: AAPL FB ORCL BAC SUNE FDX FCX EXPE NFLX MU AMZN INTC TSLA
07:23 EDTORCLOracle upgraded to Conviction Buy from Buy at Goldman
Goldman added Oracle to the Conviction Buy List and increased its price target to $47 from $45 on shares following checks that indicate cloud revenue growth will accelerate in second half 2016. Analyst Heather Bellini said investors continue to have concerns about management's cloud guidance but field work provides increasing confidence Oracle will be successful in achieving 2016 bookings targets and expects management to guide towards accelerating revenue growth and gross margin expansion in 2017. Bellini sees 2016 as a bottom in non-GAAP operating margins and expects the Street's focus to shift towards cloud execution, leading to multiple expansion.
06:46 EDTMOBISky-mobi reports Q3 EPS 7c, EPS per ADS 9c
Reports Q3 revenue $17.8M or RMB 113.3M vs. RMB 211.1M last year. Reports Q3 smartphone business revenue $17.1M.
<< 1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use